[Intertriginous rash caused by pegylated liposomal doxorubicin].
Monteagudo
B
B
Afonso-Afonso
F J
FJ
Cabanillas
M
M
Used-Aznar
M M
MM
D001365:Axilla; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006119:Groin; D006801:Humans; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects*
C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin